Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001703016 | SCV003544049 | uncertain significance | not specified | 2024-06-18 | criteria provided, single submitter | clinical testing | The c.29A>G (p.D10G) alteration is located in exon 2 (coding exon 2) of the RENBP gene. This alteration results from a A to G substitution at nucleotide position 29, causing the aspartic acid (D) at amino acid position 10 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV001572848 | SCV001797854 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001703016 | SCV001929014 | benign | not specified | no assertion criteria provided | clinical testing |